pre-IPO PHARMA

COMPANY OVERVIEW

Cancer Prevention Pharmaceuticals, Inc. (CPP) is developing therapeutics designed to reduce the risk of cancer and other diseases. CPP’s pharmaco-prevention approach has been used with success in other disease categories such as cardiovascular, neurovascular, and infectious disease.


LOCATION

  • Tucson, AZ, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://canprevent.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    sucampo-pharmaceuticals


    PRESS RELEASES


    Jun 16, 2022

    Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc.


    Jun 16, 2022

    Panbela Therapeutics, Inc. Closes Acquisition of Cancer Prevention Pharmaceuticals, Inc.


    Feb 22, 2022

    Panbela Therapeutics, Inc. to Acquire Cancer Prevention Pharmaceuticals, Inc.


    Sep 11, 2020

    Cancer Prevention Pharmaceuticals Announces NEJM Publication of Landmark Phase 3 Clinical Trial for Treatment of Familial Adenomatous Polyposis


    Jun 29, 2020

    Cancer Prevention Pharmaceuticals Submits New Drug Application to the FDA for CPP-1X/sul for Treatment of Familial Adenomatous Polyposis


    For More Press Releases


    Google Analytics Alternative